CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 196 enrolled
Drug / intervention
ibuprofen +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00913627
NCT00913627Phase 2Completed

Ibuprofen 600 Mg Extended Release (er) Single-dose Dental Pain Study

Pfizer·interventional·Posted Jun 4, 2009·Updated Mar 22, 2018

In Brief

A Phase 2 clinical trial evaluating ibuprofen, naproxen, and 1 other intervention for Pain. Completed, enrolled 196 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the efficacy and safety of a single dose of an ibuprofen 600 mg extended release formulation in post-operative dental pain. There is concern that the manufacturing process may affect the performance characteristics of the selected prototype. Therefore, two formulations of this prototype manufactured by two different processes, \[roller compaction\] and \[wet granulation\] will be included in this study. The preferred prototype manufactured by two different methods will be compared to placebo and each other. This study will also characterize the pharmacokinetic/pharmacodynamic relationship with these formulations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 4, 2009
Enrollment StartMay 7, 2009
Primary CompletionAug 1, 2009
Study CompletionAug 5, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.1 years ago

Interventions

ibuprofendrug

ibuprofendrug

naproxendrug

Placebodrug